Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

PFSA

Profusa Inc

Nov 14 • 04:00PM ET

0.1942

-0.0008 -0.41 %

Healthcare • Medical Devices • USA • NASD

Index	-	P/E	-	EPS (ttm)	-3.07	Insider Own	33.16%	Shs Outstand	41.76M	Perf Week	6.76%
Market Cap	8.11M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	29.79M	Perf Month	-36.95%
Enterprise Value	17.74M	PEG	-	EPS next Q	-	Inst Own	2.07%	Short Float	10.14%	Perf Quarter	-65.51%
Income	-16.81M	P/S	-	EPS this Y	-	Inst Trans	68.49%	Short Ratio	0.25	Perf Half Y	-98.32%
Sales	0.00M	P/B	-	EPS next Y	-	ROA	-318.61%	Short Interest	3.02M	Perf YTD	-98.34%
Book/sh	-4.00	P/C	12.29	EPS next 5Y	-	ROE	-1484.67%	52W High	12.76 -98.48%	Perf Year	-98.12%
Cash/sh	0.02	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	0.12 67.54%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.35% 17.70%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-1215.69%	Oper. Margin	-	ATR (14)	0.04	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.04	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	32.68	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.04	EPS Q/Q	-1963.01%	SMA20	-18.38%	Beta	-	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-33.50%	Rel Volume	0.48	Prev Close	0.19
Employees	2	LT Debt/Eq	-	Earnings	-	SMA200	-96.97%	Avg Volume	12.03M	Price	0.19
IPO	Jan 24, 2022	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	5,756,592	Change	-0.41%

Oct-30-25 07:30AM	Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee Oxygen and Glucose Monitoring Launches (GlobeNewswire) -9.85%
Oct-28-25 08:30AM	Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026 (GlobeNewswire)
Oct-22-25 08:30AM	Profusa Expands Sales Footprint with New Distributor for Lumee Oxygen Platform in Europe (GlobeNewswire) -8.11%
Oct-15-25 08:30AM	Profusa Expands Sales Footprint with New Distributor for Lumee Oxygen Platform in Europe (GlobeNewswire)
Oct-07-25 08:15AM	Profusa Invests Additional $1 Million in Digital Treasury Assets (GlobeNewswire)
08:30AM	Loading…
Oct-01-25 08:30AM	Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base (GlobeNewswire)
Sep-11-25 08:45AM	Report Highlights Growth in AI Biomarker Monitoring as Industry Giant's GPUs Power Next-Gen Platform (PR Newswire) +74.04%
08:30AM	Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring (GlobeNewswire)
Sep-04-25 08:30AM	Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base (GlobeNewswire) -7.94%
Sep-02-25 04:05PM	Profusa to Present at the H.C. Wainwright 27th Annual Global Investment Conference (GlobeNewswire) -7.83% -5.00%
Aug-27-25 08:45AM	Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria (GlobeNewswire)
Aug-19-25 08:15AM	Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O'Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO (GlobeNewswire) -7.99%
Aug-06-25 08:15AM	Profusa, Inc. Provides Strategy Overview and Business Update for Investors (GlobeNewswire) -7.72%
Jul-31-25 08:15AM	Profusa Secures Lumee Oxygen Platform Distributor in Spain (GlobeNewswire)
Jul-30-25 08:00AM	Profusa Announces Initial $1 Million Bitcoin Investment to Initiate Its Digital Asset Treasury Strategy (GlobeNewswire) -17.80%
08:00AM	Loading…
Jul-21-25 08:00AM	Profusa Announces $100 Million Equity Line of Credit to Initiate Bitcoin Treasury Strategy (GlobeNewswire) -17.32%
Jul-11-25 04:00PM	Profusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq (GlobeNewswire) -80.02% -19.20%

Profusa, Inc. engages in the biofeedback for chronic disease management and healthy living services. The company is headquartered in Berkeley, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFSA

Profusa Inc

Upgrade your FINVIZ experience